West Pharmaceutical Services, Inc.
US ˙ NYSE ˙ US9553061055

SecurityWST / West Pharmaceutical Services, Inc.
InstitutionAdvisor Group, Inc.
Latest Disclosed Ownership19,070 shares
Latest Disclosed Value $ 2,867,000
Advisor Group, Inc. reports 8.79% increase in ownership of WST / West Pharmaceutical Services, Inc.

On February 12, 2020 - Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 19,070 shares of West Pharmaceutical Services, Inc. (US:WST) valued at $2,866,793 USD as of December 31, 2019. The entity filed a previous 13F-HR on November 13, 2019 disclosing 17,529 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of 8.79% during the quarter. The current value of the position is $5,994,845 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2020-02-12 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 19,070 1,541 8.79 2,867 15.28 0.0198
2019-11-13 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 17,529 -504 -2.79 2,487 10.19 0.0184
2019-07-31 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 18,033 1,299 7.76 2,257 22.40 0.0173
2019-05-09 2019-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 16,734 4,199 33.50 1,844 50.04 0.0152
2019-02-11 2018-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 12,535 1,916 18.04 1,229 -6.18 0.0121
2018-11-14 2018-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 10,619 3,511 49.40 1,310 85.82 0.0132
2018-08-13 2018-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 7,108 752 11.83 705 25.67 0.0097
2018-05-15 2018-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,356 -2,603 -29.05 561 -36.54 0.0077
2018-02-14 2017-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 8,959 981 12.30 884 15.25 0.0118
2017-11-06 2017-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 7,978 -18 -0.23 767 1.46 0.0121
2017-11-03 2017-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 7,996 1,724 27.49 756 47.37 0.0133
2017-08-11 2017-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 7,996 1,724 711
2017-11-02 2017-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 6,272 228 3.77 513 0.00 0.0104
2017-05-15 2017-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,272 228 474
2017-11-02 2016-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 6,044 1,404 30.26 513 48.27 0.0116
2017-01-31 2016-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,044 1,404 454
2017-11-02 2016-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 4,640 915 24.56 346 23.13 0.0083
2016-11-08 2016-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,640 915 346
2016-08-11 2016-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,725 281
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.